innoscripta SE/€1INN
1D1W1MYTD1Y5YMAX
Capital at risk
About innoscripta SE
Innoscripta SE is a German software company specializing in cloud-based compliance solutions for research and development (R&D) tax credits and project management. Its primary product is a Software-as-a-Service (SaaS) platform that digitizes R&D workflows, assisting companies in identifying, validating, and managing R&D projects while ensuring compliant documentation for tax incentives. Founded in 2012 and headquartered in Munich, Germany, Innoscripta serves over 2,000 clients across more than twenty industries. The company operates on multi-year exclusive contracts, typically around three years, with most automatically renewed, generating revenue through commissions based on a percentage of clients' recoverable R&D costs. Innoscripta's scalable platform is designed for easy adoption across various countries and industries, supporting its growth strategy focused on international expansion and product development. (,)
- Ticker
- €1INN
- Sector
- Software & Cloud Services
- Primary listing
- XETRA
- Employees
- 396
- Headquarters
- Munich, Germany
- Website
- innoscripta.com
innoscripta SE Metrics
BasicAdvanced
€810M
15.77
€5.13
-
€4.00
4.95%
Price and volume
Market cap
€810M
52-week high
€137.00
52-week low
€61.40
Average daily volume
8.6K
Dividend rate
€4.00
Financial strength
Current ratio
2.447
Quick ratio
2.31
Long term debt to equity
29.544
Total debt to equity
30.37
Dividend payout ratio (TTM)
78.01%
Interest coverage (TTM)
381.19%
Profitability
EBITDA (TTM)
75.844
Gross margin (TTM)
72.01%
Net profit margin (TTM)
41.89%
Operating margin (TTM)
61.72%
Effective tax rate (TTM)
32.39%
Revenue per employee (TTM)
€310,000
Management effectiveness
Return on assets (TTM)
66.88%
Return on equity (TTM)
156.46%
Valuation
Price to earnings (TTM)
15.767
Price to revenue (TTM)
6.605
Price to book
21.1
Price to tangible book (TTM)
21.14
Price to free cash flow (TTM)
18.484
Free cash flow yield (TTM)
5.41%
Free cash flow per share (TTM)
4.374
Dividend yield (TTM)
4.95%
Forward dividend yield
4.95%
Growth
Revenue change (TTM)
42.47%
Earnings per share change (TTM)
51.10%
Bulls say / Bears say
In the first half of 2026, innoscripta’s revenue surged 43% year-on-year to €63.2 million, reflecting robust demand for its SaaS platform (Finance Review Daily)
Regulatory enhancements to Germany’s R&D tax allowance—raising the annual cap from €10 million to €12 million and introducing a 20% flat surcharge effective January 1, 2026—are expected to boost innoscripta’s average revenue per client (IMF)
The client base expanded to over 2,900 companies in H1 2026, up from around 1,782 at the end of 2025, demonstrating strong market penetration and product-market fit (Bitget News)
Shares fell nearly 9% after the Q2 update highlighted delays from a major internal software migration, underscoring execution risks in platform upgrades (Finance Review Daily)
Germany’s plan to cut the federal corporate income tax rate from 15% to 10% starting in 2028 may reduce the relative value of R&D tax credits, potentially dampening demand for innoscripta’s compliance platform (IMF)
With only approximately 15.3% of its 10 million shares in free float, innoscripta’s stock is exposed to heightened volatility on modest trading volumes (FT)
Data summarised monthly by Lightyear AI. Last updated on 31 Aug 2026.
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.